(IN BRIEF) Royal Philips has entered into an agreement to acquire SpectraWAVE, adding AI-powered intravascular imaging and angiography-based physiology technologies to its coronary intervention portfolio. The acquisition expands Philips’ offering with SpectraWAVE’s HyperVue Imaging System and X1-FFR, complementing existing IVUS … Read the full press release
Posted in Artificial Intelligence (AI), Business, Electronics & Machinery, Healthcare, Investment, Management, Netherlands, News, Science, Technology
Tagged AI medical imaging, artificial intelligence, Azurion, Bert van Meurs, Coronary Artery Disease, coronary physiology, DeepOCT, Eman Namati, Enhanced Vascular Imaging, HyperVue Imaging System, iFR, image-guided therapy, intravascular imaging, IVUS, Near-infrared spectroscopy, percutaneous coronary intervention, Philips Adds AI-Powered Intravascular Imaging and Physiology Technologies with SpectraWAVE Deal, Roy Jakobs, Royal Philips, SpectraWAVE, X1-FFR
(IN BRIEF) A nationwide retrospective study presented at EACVI 2025 found that AI-derived fractional flow reserve from coronary CT (FFR-CT) is a strong independent predictor of future cardiovascular events in patients undergoing evaluation for suspected stable coronary artery disease. Using … Read the full press release
Posted in Artificial Intelligence (AI), Austria, Business, Education, France, Healthcare, Industrial, Management, Marketing, News, Non Profit, Pharma & Biotech, Science, Technology
Tagged AI-Derived Coronary Flow Assessment Identifies High-Risk Patients in Stable Coronary Artery Disease, artificial intelligence imaging, CAD, cardio-oncology, cardiovascular mortality, CCTA, clinical outcomes, Coronary Artery Disease, coronary computed tomography angiography, CT-derived fractional flow reserve, EACVI 2025, ESC, FFR-CT, FISH&CHIPS study, Jack Bell, myocardial infarction risk, Non-invasive Imaging, prognostic imaging, revascularisation, Timothy Fairbairn, Vienna
(IN BRIEF) The COMBINE-CT consortium, led by Philips and supported by a €6.5 million grant from the Innovative Health Initiative (IHI), is dedicated to improving the diagnosis and treatment of coronary artery disease (CAD). CAD, characterized by the accumulation of … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?